FDA Compliance 2012 - Major CGMP Issues for 2012 - Webinar by ComplianceOnline

This 90-minute training on Major cGMP Issues for 2012 will show what drug and device companies can do proactively to address failures over cGMP issues and ensure better regulatory compliance.

U. S. FDA-regulated companies are responsible for understanding current Good Manufacturing Practices as defined in the Code of Federal Regulations ( 21 CFR Part 111, 210/211, and 820). They are then required to translate those regulations into procedures and work instructions.